Connor, Clark & Lunn Investment Management Ltd. Outset Medical, Inc. Transaction History

Connor, Clark & Lunn Investment Management Ltd.

$18.8 Billion
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2024 May 09, 2024	BUY	$1.99 - $5.64 $687,232 - $1.95 Million	345,343 New	345,343 $766,000
Q3 2023 Nov 13, 2023	BUY	$10.52 - $20.68 $169,561 - $333,320	16,118 New	16,118 $175,000

Others Institutions Holding OM

# of Institutions

Shares Held

19.9M

Call Options Held

66.8K

Put Options Held

60.3K

Vanguard Group Inc Valley Forge, PA

2.64M
Shares

$2.99 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

1.89M
Shares

$2.13 Million
0.0% of portfolio
Ameriprise Financial Inc Minneapolis, MN

1.81M
Shares

$2.05 Million
0.0% of portfolio
Gmt Capital Corp Atlanta, GA

1.47M
Shares

$1.66 Million
0.04% of portfolio
Ensign Peak Advisors, Inc Salt Lake City, UT

1.39M
Shares

$1.57 Million
0.0% of portfolio

View Full List

About Outset Medical, Inc.

Ticker OM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 48,007,300
Market Cap $54.2M
Description
Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was ...

More about OM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Account